High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

Table 2

hsTnT levels in relation to different modalities of drug therapy.

Therapy	hsTnT levels (ng/mL)	𝑃 value
Aspirin	Yes: 0.014 (0.007–0.027)	0.583
	No: 0.008 (0.008–0.008)
Clopidogrel	Yes: 0.013 (0.001–0.026)	0.383
	No: 0.029 (0.029–0.029)
ARBs	Yes: 0.009 (0.004–0.016)	0.557
	No: 0.010 (0.005–0.026)
Beta-blocker	Yes: 0.011 (0.005–0.026)	0.478
	No: 0.009 (0.004–0.021)
ACE inhibitors	Yes: 0.010 (0.005–0.023)	0.771
	No: 0.009 (0.005–0.024)
CA	Yes: 0.012 (0.007–0.023)	0.370
	No: 0.009 (0.004–0.021)
Statins	Yes: 0.013 (0.005–0.029)	0.087
	No: 0.009 (0.004–0.029)

Values are median (IQR). ARBs: angiotensin receptor blockers; ACE: angiotensin-converting enzyme; CA: calcium antagonists.